wellrank.ai
Sign In

How much is Ozempic per month without insurance and how do people afford it?

ClaudepricingCollected Aug 11, 2026, 13:14 UTC

Verbatim response from Claude

Ozempic Cost Without Insurance

Retail price: approximately $900–$1,000+ per month for a monthly supply (typically one pen).


How People Afford It

Manufacturer Savings:

  • Novo Nordisk's savings card – eligible commercially insured patients may pay as little as $25/month, but this doesn't help the uninsured

Discount Programs:

  • GoodRx – can reduce cost to roughly $800–$950, not a huge savings but worth checking
  • NeedyMeds – helps connect low-income patients with assistance programs
  • Novo Nordisk Patient Assistance Program – free medication for qualifying low-income uninsured patients

Alternative Options:

  • Compounded semaglutide (the active ingredient) from telehealth companies like Hims & Hers, Ro, or LifeMD – previously available for $200–$400/month, though FDA has recently restricted this
  • Cheaper alternativesOzempic's sister drug Rybelsus (oral pill) sometimes costs less
  • Generic versions aren't available yet

Practical Tips:

  • Ask your doctor for samples
  • Check CostPlus Drugs (Mark Cuban's pharmacy) periodically
  • Appeal to insurance if prescribed for Type 2 diabetes (its approved use)

The affordability gap is a real problem many patients face right now.

Brands mentioned in this answer

More Ozempic answers

See all Ozempic rankings and answers →

Is this answer wrong about your brand?

AI engines repeat outdated pricing, wrong ingredients, and misread positioning every day. Tell us what this answer gets wrong and we will include a correction review in your free AI Visibility Audit.

This answer is reproduced verbatim from the engine's API at collection time and may contain errors or outdated claims. It is presented as evidence of what AI engines tell buyers, not as medical or purchasing advice.

Is your brand missing from this answer?

Get your AI Visibility Audit: every buyer intent question you are losing, who wins them, and the sources that decide the answer.